1167 related articles for article (PubMed ID: 12384415)
1. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
[TBL] [Abstract][Full Text] [Related]
2. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
4. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human cord blood engraftment between immunocompromised mouse strains.
McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE
Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133
[TBL] [Abstract][Full Text] [Related]
6. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
[TBL] [Abstract][Full Text] [Related]
7. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
8. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice.
Ishikawa F; Livingston AG; Wingard JR; Nishikawa Si; Ogawa M
Exp Hematol; 2002 May; 30(5):488-94. PubMed ID: 12031656
[TBL] [Abstract][Full Text] [Related]
9. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P
Cytotherapy; 2010; 12(1):45-9. PubMed ID: 19929453
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.
Shultz LD; Banuelos SJ; Leif J; Appel MC; Cunningham M; Ballen K; Burzenski L; Greiner DL
Exp Hematol; 2003 Jun; 31(6):551-8. PubMed ID: 12829032
[TBL] [Abstract][Full Text] [Related]
12. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.
Ishikawa F; Yasukawa M; Lyons B; Yoshida S; Miyamoto T; Yoshimoto G; Watanabe T; Akashi K; Shultz LD; Harada M
Blood; 2005 Sep; 106(5):1565-73. PubMed ID: 15920010
[TBL] [Abstract][Full Text] [Related]
13. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
14. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
15. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
[TBL] [Abstract][Full Text] [Related]
16. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice.
Yahata T; Ando K; Nakamura Y; Ueyama Y; Shimamura K; Tamaoki N; Kato S; Hotta T
J Immunol; 2002 Jul; 169(1):204-9. PubMed ID: 12077246
[TBL] [Abstract][Full Text] [Related]
17. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
18. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells.
McKenzie JL; Gan OI; Doedens M; Dick JE
Blood; 2005 Aug; 106(4):1259-61. PubMed ID: 15878972
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
20. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
